T0	KEYPHRASE-NOTYPES 5 13	patients,"ive","wit"
T1	KEYPHRASE-NOTYPES 32 37	study,"the","bec"
T2	KEYPHRASE-NOTYPES 49 63	adverse events," of"," tw"
T3	KEYPHRASE-NOTYPES 80 88	thrombus," of","(bo"
T4	KEYPHRASE-NOTYPES 98 102	drug," on",", o"
T5	KEYPHRASE-NOTYPES 120 144	staphylococcal infection," of","(on"
T6	KEYPHRASE-NOTYPES 149 156	placebo,"(on",", o"
T7	KEYPHRASE-NOTYPES 178 195	allergic reaction,"an ","(on"
T8	KEYPHRASE-NOTYPES 200 204	drug,"(on",", a"
T9	KEYPHRASE-NOTYPES 236 246	joint pain,"ing","(on"
T10	KEYPHRASE-NOTYPES 251 258	placebo,"(on"," th"
T11	KEYPHRASE-NOTYPES 274 298	narcotic pain medication,"red"," Fo"
T12	KEYPHRASE-NOTYPES 305 313	patients,"our","rem"
T13	KEYPHRASE-NOTYPES 330 335	study,"the","des"
T14	KEYPHRASE-NOTYPES 344 358	adverse events,"ite","tha"
T15	KEYPHRASE-NOTYPES 380 397	early termination,"her","of "
T16	KEYPHRASE-NOTYPES 401 417	study medication," of","(th"
T17	KEYPHRASE-NOTYPES 428 432	drug," on"," tw"
T18	KEYPHRASE-NOTYPES 443 461	allergic reactions,"ith"," an"
T19	KEYPHRASE-NOTYPES 476 490	abdominal pain,"ith"," or"
T20	KEYPHRASE-NOTYPES 495 510	hospitalization," or","(on"
T21	KEYPHRASE-NOTYPES 519 523	drug," on"," ch"
T22	KEYPHRASE-NOTYPES 525 540	cholecystectomy,"ug;","at "
T23	KEYPHRASE-NOTYPES 544 548	week," at","16)"
T24	KEYPHRASE-NOTYPES 564 572	patients,"ese"," ra"
T25	KEYPHRASE-NOTYPES 574 581	ratings,"ts,","at "
T26	KEYPHRASE-NOTYPES 585 590	weeks," at","12 "
T27	KEYPHRASE-NOTYPES 645 668	treatment randomization,"ing"," Th"
T28	KEYPHRASE-NOTYPES 674 691	adverse reactions,"The","of "
T29	KEYPHRASE-NOTYPES 715 723	patients,"ine","wer"
T30	KEYPHRASE-NOTYPES 781 796	study treatment,"the","(pr"
T31	KEYPHRASE-NOTYPES 798 806	presence,"nt ","of "
T32	KEYPHRASE-NOTYPES 812 821	PICC line,"f a","or "
T33	KEYPHRASE-NOTYPES 825 835	medication," or",", f"
T34	KEYPHRASE-NOTYPES 844 848	rate,"r a","of "
T35	KEYPHRASE-NOTYPES 852 884	treatment-related adverse events," of","of "
T36	KEYPHRASE-NOTYPES 910 918	patients,"ong","giv"
T37	KEYPHRASE-NOTYPES 928 939	ceftriaxone," IV","and"
T38	KEYPHRASE-NOTYPES 965 973	patients,"ong","giv"
T39	KEYPHRASE-NOTYPES 983 990	placebo," IV"," al"
T40	KEYPHRASE-NOTYPES 996 1004	patients,"all","rec"
